|
 |
Leuprolide acetateThis page contains recent news articles, when available, and an overview of Leuprolide acetate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.After cryogenic surgery, or the freezing of cancer cells; taking the testosterone reducer leuprolide acetate; and changing his lifestyle, blood tests to ... The Tennessean QLT Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new ... - Nov 13, 2009 The Eligard product line includes one, three, four and six month commercial formulations of Atrigel technology combined with leuprolide acetate. ... PR-inside.com (press release) Leuprolide Acetate Stabilizes Cognitive and Functional Decline in … - May 16, 2006 RALEIGH, NC, May 16 /PRNewswire/ -- Leuprolide acetate, when used in conjunction with standard Alzheimer's therapy, was shown to stabilize the cognitive and ... Free with registration - PR Newswire - AccessMyLibrary.com $16 million raised for Alzheimer's drug. - Feb 15, 2005 Leuprolide acetate would be Voyager's first drug on the market. ... Investors in Voyager are betting that leuprolide acetate will at least slow the onset of ... Free with registration - News & Observer - AccessMyLibrary.com Leuprolide Acetate Maintains Functional Capabilities In Women With … - Jul 18, 2006 MADRID - Women with mild to moderate Alzheimer's disease who are treated with the investigational hormone drug leuprolide acetate and conventional therapy ... Medical News Today - Medical News Today (press release) Leuprolide Acetate Stabilises Cognitive Decline in Women With … - Apr 24, 2006 By Chris Berrie. GENEVA, SWITZERLAND -- April 24, 2006 -- Leuprolide acetate, a drug that is commonly used to treat prostate cancer, appears to produce a ... DG News Leuprolide acetate may delay Alzheimer's decline.(Clinical Rounds) - Oct 1, 2006 MADRID -- Leuprolide acetate may help forestall functional decline in patients with mild to moderate Alzheimer's disease, Christopher W. Gregory, Ph.D., ... Free with registration - Family Practice News - AccessMyLibrary.com Article: [ BIZ BRIEFS ] - Chicago Sun-Times | HighBeam Research -... - Aug 19, 2005 Article: LUPRON DEPOT 3.75 mg (LEUPROLIDE ACETATE FOR DEPOT ... PR Newswire; April 4, ... Lupron Depot (leuprolide acetate), a synthetic ... ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Press Release: Leuprolide Acetate Stabilizes Cognitive and Functional... - May 16, 2006 Leuprolide Acetate Stabilizes Cognitive and Functional Decline in Women With Alzheimer's Disease, Study Shows. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Assisted Reproduction; Cetrorelix and leuprolide acetate comparably … - Mar 21, 2005 They concluded, "Cetrorelix and leuprolide acetate appear to have comparable efficacy and safety, although cetrorelix has the advantage of typically ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones … Levels in Patients Using Leuprolide Acetate in Locally Advanced … - Jan 2, 2006 40 patients treated with a 3-monthly formulation of leuprolide acetate and ... Four patients (10%) treated with leuprolide acetate failed to reach the ... UroToday International Journal … Release: Marketing of Viadur(R) (leuprolide acetate implant) to... - Dec 20, 2007 Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Iron deficiency in non-dialysis chronic kidney disease - Jun 18, 2008 After discontinuation of leuprolide acetate, menorrhagia recurred, ... Two years after discontinuing leuprolide acetate treatment, the patient had still not ... Nature.com Assisted Reproduction; Cetrorelix and leuprolide acetate comparably … - Mar 25, 2005 They concluded, "Cetrorelix and leuprolide acetate appear to have comparable efficacy and safety, although cetrorelix has the advantage of typically ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Assisted Reproduction; Cetrorelix and leuprolide acetate comparably … - Mar 26, 2005 They concluded, "Cetrorelix and leuprolide acetate appear to have comparable efficacy and safety, although cetrorelix has the advantage of typically ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Leuprolide acetate may delay Alzheimer's decline.(Clinical Rounds) | ... - Oct 1, 2006 Leuprolide acetate may delay Alzheimer's decline.(Clinical Rounds) ... find Family Practice News articles. MADRID -- Leuprolide acetate may help forestall ... Pay-Per-View - Family Practice News - HighBeam Research Gonadotropin-releasing hormone analogues for infertility - Mar 21, 2008 Leuprolide acetate (Lupron) is injected under the skin, while depo leuprolide acetate (Lupron Depot) is injected into a muscle. About 10 days of injections ... WebMD Sanofi-Aventis Announces Commercial Availability of Twice-Yearly … - Feb 17, 2005 17 /PRNewswire-FirstCall/ -- The sanofi-aventis Group announced today the commercial availability in the United States of ELIGARD 45 mg (leuprolide acetate ... RedOrbit Are changes in US practices for androgen deprivation therapy financial... - Jun 16, 2008 The authors reviewed publicly available data to determine trends in reimbursable Medicare codes for the LHRH agonists leuprolide acetate (Lupron ® ; Abbott ... Nature.com Leuprolide acetate may forestall decline in AD.(Neurology) - Nov 1, 2006 MADRID -- Leuprolide acetate may help forestall functional decline in patients with mild to moderate Alzheimer's disease, Christopher W. Gregory, Ph.D., ... $4.95 - Internal Medicine News - ECNext Article: LLNS.(AGENCIES)(Susan Flinn hired at Lyons/Lavey/Nickel/Swift... - Apr 1, 2007 Article: LUPRON DEPOT 3.75 mg (LEUPROLIDE ACETATE FOR DEPOT ... ... TM) is now available for use with Lupron Depot(R) (leuprolide acetate for depot ... to ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Paraphilia; Leuprolide acetate may be effective treatment for... - Jan 18, 2005 2005 JAN 18 - (NewsRx.com & NewsRx.net) -- Study results suggest that leuprolide acetate may be an effective treatment for young adult patients with ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Leuprolide acetate may forestall decline in AD.(Neurology) | Article... - Nov 1, 2006 Leuprolide acetate may forestall decline in AD.(Neurology) ... find Internal Medicine News articles. MADRID -- Leuprolide acetate may help forestall ... Pay-Per-View - Internal Medicine News - HighBeam Research Paraphilia; Leuprolide acetate may be effective treatment for... - Jan 21, 2005 2005 JAN 21 - (NewsRx.com & NewsRx.net) -- Study results suggest that leuprolide acetate may be an effective treatment for young adult patients with ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Leuprolide acetate seems to forestall Alzheimer's decline.(Geriatric ... - Oct 1, 2006 Leuprolide acetate seems to forestall Alzheimer's decline.(Geriatric Psychiatry) ... find Clinical Psychiatry News articles. MADRID -- Leuprolide acetate ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Leuprolide acetate suppresses pedophilic urges and arousability.(clini... - Dec 1, 2005 Traditional treatment of pedophilia has focused on cognitive-behavioral psychotherapy alone and, more recently, cognitive-behavioral psychotherapy combined ... $4.95 - Archives of Sexual Behavior - ECNext … Disease; Study shows leuprolide acetate stabilizes cognitive... - Jun 14, 2006 2006 JUN 14 - (NewsRx.com) -- Leuprolide acetate, when used in conjunction with standard Alzheimer therapy, was shown to stabilize the cognitive and ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Sexual Offenders With Mental Illness: Special Considerations for a … - Sep 1, 2007 Androgen reduction therapy with depot-leuprolide acetate is being used in other ... (The prescription of SSRIs and depot-leuprolide acetate for the ... Psychiatric Times Raleigh, NC, drug company start-up sells stock at auction. - Oct 24, 2005 The active ingredient in Memryte is leuprolide acetate, a substance that suppresses ... Products containing leuprolide acetate are on the market to treat ... Free with registration - News & Observer - AccessMyLibrary.com … second phase 2 study of leuprolide acetate for treating Alzheimer ... - May 31, 2006 The active ingredient in VP4896, leuprolide acetate, has been used safely for over 20 years as a treatment for prostate cancer. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones FDA Approves Pfizer's Depo-subQ provera 104(TM) for Management of … - Mar 29, 2005 Clinical data showed that depo-subQ provera 104 is equally as effective for treating pain caused by endometriosis as leuprolide acetate (LA), ... Free with registration - PR Newswire - AccessMyLibrary.com Competitors by Product Report - Apr 14, 2007 Abbott Laboratories (ABT) Products:. Lupron/Lupron Depot Series (Leuprolide Acetate). Novartis AG (ADR) (NVS) Products:. Eon Labs Leuprolide Acetate ... $75.00 - Revere Reports - Revere Treatment options for prostate adenocarcinoma - Nov 10, 2008 The patient was started on androgen deprivation therapy with leuprolide acetate and achieved a transient fall in his PSA levels. ... HemOncToday Glucose intolerance during hormonal therapy for prostate cancer - Oct 19, 2006 11 reported that in a 26-year-old woman with endometriosis and DM, the evening blood glucose levels after leuprolide acetate were higher than those before ... Nature.com Scientist's theory on diseases of aging being put to test. - Sep 20, 2005 Leuprolide acetate dramatically lowers levels of luteinizing hormone. The drug also brings down testosterone and estrogen. In its earlier clinical trials, ... Free with registration - Milwaukee Journal Sentinel - AccessMyLibrary.com Senior Health Report -- Health News for Seniors About Alzheimer's - May 15, 2006 Leuprolide acetate, when used in conjunction acetylcholinesterase inhibitors ... Leuprolide acetate, a luteinizing hormone-releasing hormone (LHRH) agonist, ... Senior Health Report Stock Market Update, IPO profiles, Earnings Call Transcripts,... - Sep 9, 2005 Administration of leuprolide acetate using the Memryte implant is designed to minimize an initial dosage peak and provide a steady leuprolide acetate level ... 123Jump.com Press Release: Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High... - Jun 3, 2008 Article: FDA Approves Eligard(R) 30mg (Leuprolide Acetate for ... PR Newswire; February 18, 2003 ; 700+ words ... ... approval from the U.S. Food and Drug ... Pay-Per-View - PR Newswire - HighBeam Research Novel Approach May Offer New Hope to Women With Alzheimer's … - Jul 17, 2006 ..."Women treated with leuprolide acetate and the current standard of care, ... "Our trial result demonstrates that leuprolide acetate may benefit a spectrum ... Genetic Engineering News - Genetic Engineering News (press release) Eligard(R) six-month formulation successfully completes European … - Aug 31, 2007 The Atrigel technology allows for sustained delivery of leuprolide acetate for periods ranging from one to six months. Eligard works by lowering the levels ... $4.95 - PR Newswire - ECNext Risks to women in embryo cloning - Feb 25, 2005 Risks associated with leuprolide acetate (Lupron) -- a drug used to ''shut ... This would include the release of unpublished data on leuprolide acetate ... Boston Globe Voyager Pharmaceutical Corporation Announces the Formation of its … - Jul 13, 2006 The active ingredient in VP4896, leuprolide acetate, has been used safely for more than 20 years as a treatment for prostate cancer. ... Free with registration - PR Newswire - AccessMyLibrary.com Dimethyl sulfoxide USP, PhEur in approved pharmaceutical products and... - May 1, 2008 Alza's Duros technology is used to administer leuprolide acetate in a sustained fashion over 12 months. This device contains a solution of dimethyl ... $9.94 - Pharmaceutical Technology - Alacra Store Prostate Cancer; Injectable hormonal therapy for advanced prostate … - Mar 15, 2005 2005 MAR 15 - (NewsRx.com) -- The sanofi-aventis Group announced the commercial availability in the United States of ELIGARD 45 mg (leuprolide acetate for ... Pay-Per-View - Cancer Weekly - Factiva, from Dow Jones Press Release: Super Prostate Product - More Beta-sitosterol, all... - Feb 28, 2008 Australia/ New Zealand marketing rights for its three Leuprogel(TM) Depot products, leuprolide acetate for subcutaneous depot ... body to inhibit the growth ... Pay-Per-View - PR Newswire - HighBeam Research New treatment for endometriosis pain has bone-loss warning.(Pain … - Sep 1, 2005 Depo subQ provera 104 (DMPA-SC), which contains 104 mg medroxyprogesterone acetate, treats endometriosis pain as effectively as leuprolide acetate, ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com QLT cancer drug approved in Germany - Dec 1, 2006 Eligard incorporates a luteinizing hormone-releasing hormone agonist, or LHRH agonist, known as leuprolide acetate with QLT's proprietary Atrigel Delivery ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones A case of raging hormones? UW scientist's theory on diseases of aging... - Sep 18, 2005 Leuprolide acetate dramatically lowers levels of luteinizing hormone. The drug also brings down testosterone and estrogen. In its earlier clinical trials, ... $2.95 - Milwaukee Journal Sentinel - NewsBank Article: A case of raging hormones?; UW scientist's theory on... - Sep 18, 2005 Leuprolide acetate dramatically lowers levels of luteinizing hormone. The drug also brings down testosterone and estrogen. In its earlier clinical trials, ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research Alzheimer Disease; Company announces acceptance of DURIN IND … - Jan 23, 2005 ..."The launch of this study using our unique dose of DURIN-leuprolide acetate optimized for the treatment of Alzheimer disease is an exciting event for ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones Prostate Cancer; Injectable hormonal therapy for advanced prostate … - Mar 19, 2005 2005 MAR 19 - (NewsRx.com) -- The sanofi-aventis Group announced the commercial availability in the United States of ELIGARD 45 mg (leuprolide acetate for ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones SOUTH CAROLINA DEPARTMENT OF HEALTH AND HUMAN … - Nov 29, 2005 NOTE: Leuprolide acetate and Rho(D) immune globulin do not require PA when used ... Upon receipt of a prescription for leuprolide acetate or Rho(D) immune ... Pay-Per-View - US Fed News - Factiva, from Dow Jones Implant slows symptoms of Alzheimer's - Jul 25, 2006 Each implant contains a medicine called leuprolide acetate, which has been used for over 20 years to treat prostate cancer. Now new research suggests it ... Daily Mail Leaders' pasts haunt Voyager: Behind an Alzheimer's drug, a legal... - Jun 25, 2006 It was while he was running the clinics that Bowen first heard about leuprolide acetate, a drug used to treat prostate cancer. According to SEC filings, ... Free with registration - News & Observer - AccessMyLibrary.com Article: Correction.(Correction Notice) - OB GYN News | HighBeam … - Mar 1, 2005 ...words ... ... which contains 104 mg medroxyprogesterone acetate, treats endometriosis pain as effectively as leuprolide acetate, but is associated . ... Pay-Per-View - OB GYN News - HighBeam Research Ovarian Hyperstimulation Syndrome; Studies from National Institutes... - Dec 11, 2006 GnRH-antagonist (ganirelix acetate) treatment was started and leuprolide acetate discontinued in women who failed to respond to a reduction in gonadotrophin ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Investor Group acquires a minority stake in Norwood Abbey Ltd - Deal ... - Nov 3, 2005 Depot (leuprolide acetate) Endometriosis M Norwood Abbey Ltd TAP Pharmaceutical Products Norwood Abbey Page # of ## #…acetate) Female Sexual Dysfunction M ... Pay-Per-View - deals - Alacra Store Alzheimer Disease; Trial enrollment completed for DURIN-based … - Feb 28, 2005 Voyager Pharmaceutical owns a broad-based patent covering the use of leuprolide acetate and other compounds for the treatment of Alzheimer disease. ... Pay-Per-View - Mental Health Weekly Digest - Factiva, from Dow Jones International Approvals: Adderall XR, Gynazole-1, Leuplin SR - Aug 29, 2005 It is approved by the US Food and Drug Administration (leuprolide acetate [Lupron], made by Tap Pharmaceutical Products, Inc.) for use alone and with ... Medscape Article: New drug is approved for endometriosis pain: depo subQ... - May 1, 2005 New drug is approved for endometriosis pain: depo subQ provera 104 is as effective as leuprolide acetate but is associated with fewer adverse effects. Pay-Per-View - Internal Medicine News - HighBeam Research Voyager Pharmaceutical Corporation Completes Second Phase II Clinical... - May 3, 2006 The active ingredient in VP4896, leuprolide acetate, has been used safely for over 20 years as a treatment for prostate cancer. Voyager's Phase III trial ... Free with registration - PR Newswire - AccessMyLibrary.com Voyager Pharmaceutical Corporation Completes Second Phase II Clinical... - May 4, 2006 The active ingredient in VP4896, leuprolide acetate, has been used safely for over 20 years as a treatment for prostate cancer. Voyager's Phase III trial ... Medical News Today - Medical News Today (press release) Sosei files to market Japanese Eligard - Mar 1, 2005 SOT-375, known as Eligard in the US, is an injectable formulation of leuprolide acetate designed to deliver 3.75mg of the drug substance at a controlled ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Tap Pharmaceutical Products, Inc. v. Atrix Laboratories, Inc., No. 03... - Feb 27, 2006 Both products offer sustained release of the same drug -- leuprolide acetate, an LHRH agonist -- used in the treatment of advanced prostate cancer. ... $2.95 - U.S. District Court, Northern District... - VersusLaw DRUG CAPSULE WHAT YOU SHOULD KNOW | Article from The … - Aug 29, 2005 LEUPROLIDE ACETATE What it does: Leuprolide acetate is a hormone that reduces levels of follicle-stimulating hormone (... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research Press Release: Bob DeRodes, Executive Vice President and Chief … - Apr 3, 2008 Article: LUPRON DEPOT 3.75 mg (LEUPROLIDE ACETATE FOR DEPOT ... PR Newswire; April 4, 1995 ; 700+ words ... ... Drug Administration (FDA) to indicate Lupron ... Pay-Per-View - PR Newswire - HighBeam Research Scientist's Theory on Diseases of Aging Being Put to Test - Sep 27, 2005 Leuprolide acetate dramatically lowers levels of luteinizing hormone. The drug also brings down testosterone and estrogen. In its earlier clinical trials, ... RedOrbit FDA Approvals: Boniva, Baraclude, depo-subQ provera 104 - Mar 31, 2005 ...relief statistically equivalent to that of leuprolide acetate across all endometriosis-associated categories, including pelvic pain, pelvic tenderness, ... Medscape Article: New treatment approved for endometriosis pain: Depo subQ … - May 15, 2005 Depo subQ provera 104 (DMPA-SC), which contains 104 mg medroxyprogesterone acetate, treats endometriosis pain as effectively as leuprolide acetate, ... Pay-Per-View - Family Practice News - HighBeam Research Does Lupron Dosage Make a Difference in Outcome when Treating … - Mar 1, 2006 Leuprolide acetate in its depot form is the most frequently used preparation for treatment of central precocious puberty in the United States. ... Journal of Clinical Endocrinology and... Researcher's theory on aging put to test - Sep 22, 2005 Leuprolide acetate dramatically lowers levels of luteinizing hormone. The drug also brings down testosterone and estrogen. In its earlier clinical trials, ... $2.95 - Erie Times-News - NewsBank Endometriosis; FDA approves depo-subQ provera 104 for management of … - Apr 25, 2005 Clinical data showed that depo-subQ provera 104 is equally as effective for treating pain caused by endometriosis as leuprolide acetate, marketed as Lupron ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones GnRH agonist may curb ovarian failure in lupus.(Obstetrics) - Mar 1, 2005 Among the 20 patients treated with leuprolide acetate in depot suspension (Lupron, 3.75 mg a month), only 1 developed ovarian failure at the end of 3 years, ... Free with registration - OB GYN News - AccessMyLibrary.com Should patients with high-risk prostate cancer receive 6 months or 3... - Jul 5, 2007 AST consisted of treatment with the luteinizing hormone-releasing hormone analogs goserelin or leuprolide acetate, plus the nonsteroidal antiandrogens ... Nature.com Intermittent androgen blockade should be regarded as standard therapy... - Feb 11, 2008 The European phase III study EC 507 (RELAPSE) compared intermittent and continu-ous AD with leuprolide acetate (and flare prophylaxis with cyproterone ... Nature.com Endometriosis; FDA approves depo-subQ provera 104 for management of … - Apr 30, 2005 Clinical data showed that depo-subQ provera 104 is equally as effective for treating pain caused by endometriosis as leuprolide acetate, marketed as Lupron ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones PFIZER INC - Regulatory Approval. | Article from PR Newswire UK … - Mar 29, 2005 Clinical data showed that depo-subQ provera 104 is equally as effective for treating pain caused by endometriosis as leuprolide acetate (LA), ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research Press Release: sanofi-aventis Announces Commercial Availability of … - Feb 17, 2005 Article: FDA Approves Eligard(R) 30mg (Leuprolide Acetate for ... PR Newswire; February 18, 2003 ; 700+ words ... ... treatment of advanced prostate cancer. ... Pay-Per-View - PR Newswire - HighBeam Research Dysmenorrhea. - Jan 15, 2005 Leuprolide acetate 3.75 mg IM monthly 473 (Lupron) NSAIDs ([dagger]) Diclofenac (Voltaren) 50 mg three times daily 22 (12 to 16) ... Pay-Per-View - American Family Physician - Factiva, from Dow Jones Dysmenorrhea. - Jan 15, 2005 Treatment to suppress the menstrual cycle with danazol (Danocrine) or leuprolide acetate (Lupron) may be considered, rarely, in refractory cases. ... $4.95 - American Family Physician - ECNext Alzheimer Disease; Company announces acceptance of DURIN IND … - Jan 18, 2005 ..."The launch of this study using our unique dose of DURIN-leuprolide acetate optimized for the treatment of Alzheimer disease is an exciting event for ... Pay-Per-View - Science Letter - Factiva, from Dow Jones QLT Inc. Sosei files Japan marketing authorization application for... - Mar 30, 2005 SOT-375 is an injectable formulation of leuprolide acetate designed to deliver 3.75 ... Leuprolide acetate is a luteinizing hormone-releasing hormone (LHRH) ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Prostate Cancer; Sosei files Japan marketing authorization application... - Mar 28, 2005 SOT-375 is an injectable formulation of leuprolide acetate designed to deliver 3.75 ... Leuprolide acetate is a luteinizing hormone-releasing hormone (LHRH) ... Pay-Per-View - Clinical Trials Week - Factiva, from Dow Jones Implant provides long-acting treatment for prostate cancer. - Jan 10, 2005 The other 12-month LHRH product, leuprolide acetate (Viadur, Bayer/ Johnson & Johnson), is a titanium cylinder with an osmotic pump that pushes the fluid ... $9.94 - Drug Topics - Alacra Store Press Release: Sosei Files Marketing Authorisation Application for... - Feb 28, 2005 SOT-375 is an injectable formulation of leuprolide acetate designed to deliver 3.75 ... Leuprolide acetate is a luteinizing hormone-releasing hormone (LHRH) ... Pay-Per-View - PR Newswire - HighBeam Research Prostate Cancer; Injectable hormonal therapy for advanced prostate … - Mar 20, 2005 2005 MAR 20 - (NewsRx.com) -- The sanofi-aventis Group announced the commercial availability in the United States of ELIGARD 45 mg (leuprolide acetate for ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Prostate Cancer; Sosei files Japan marketing authorization application... - Apr 2, 2005 SOT-375 is an injectable formulation of leuprolide acetate designed to deliver 3.75 ... Leuprolide acetate is a luteinizing hormone-releasing hormone (LHRH) ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Alzheimer Disease; Company announces acceptance of DURIN IND … - Jan 21, 2005 ..."The launch of this study using our unique dose of DURIN-leuprolide acetate optimized for the treatment of Alzheimer disease is an exciting event for ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones Joseph DeVeaugh-Geiss, MD, expands role as Interim Chief Medical … - Jan 16, 2006 Voyager's most advanced product candidate is Memryte, a proprietary, small, biodegradable implant that is comprised of leuprolide acetate and a polymer, ... carolinanewswire.com Voyager Pharmaceutical Corporation to Present at the 9th International... - Apr 18, 2006 Voyager's most advanced product candidate is VP4896, a proprietary, small, biodegradable implant that is comprised of leuprolide acetate and a polymer, ... Free with registration - PR Newswire - AccessMyLibrary.com DURECT Corporation Announces Completion of Clinical Trial Enrollment ... - Jan 28, 2005 Voyager Pharmaceutical owns a broad-based patent covering the use of leuprolide acetate and other compounds for the treatment of Alzheimer's Disease. ... RedOrbit Rich Daly Joins TAP As Senior Marketing Executive - Feb 2, 2006 TAP markets Prevacid(R) (lansoprazole) and Lupron Depot(R) (leuprolide acetate for depot suspension). For more information about TAP Pharmaceutical Products ... RedOrbit Voyager Pharmaceutical announces progress in enrollment for Alzheimer... - Dec 23, 2005 VP4896 is a proprietary implantable form of leuprolide acetate developed by Voyager Pharmaceutical as a potential treatment for mild to moderate Alzheimer's ... carolinanewswire.com 6-month LHRH formulation receives FDA approval.(New Products & … - Jan 1, 2005 Leuprolide acetate is already approved for 1-month (7.5 mg), 3-month (22.5mg), and 4-month (30 mg) depots. The liquid products are injected subcutaneously ... Free with registration - Urology Times - AccessMyLibrary.com CMS fails to use AUA data in practice expense RVU update; AUA also … - Mar 1, 2006 Inequities involved in reimbursement under the Competitive Acquisition Program (CAP) with respect to leuprolide acetate and goserelin acetate. ... $4.95 - Urology Times - ECNext GnRH agonist may curb ovarian failure in lupus.(Obstetrics) | Article... - Mar 1, 2005 Among the 20 patients treated with leuprolide acetate in depot suspension (Lupron, 3.75 mg a month), only 1 developed ovarian failure at the end of 3 years, ... Pay-Per-View - OB GYN News - HighBeam Research Press Release: Sosei Files Japan Marketing Authorization Application... - Feb 28, 2005 SOT-375 is an injectable formulation of leuprolide acetate designed to deliver 3.75mg of ... Article: FDA Approves Eligard(R) 30mg (Leuprolide Acetate for . ... Pay-Per-View - PR Newswire - HighBeam Research Does androgen suppression plus radiation therapy lead to changes in … - Jun 21, 2007 All patients were treated with hormonal therapy (leuprolide acetate or goserelin injected every 3 months for 9 months; oral bicalutamide 50 mg daily was ... Nature.com DURECT Corporation Announces First Quarter 2005 Financial Results … - May 3, 2005 In January 2005, DURECT and Voyager Pharmaceutical announced the completion of enrollment for the Phase I study of our DURIN(TM)-based leuprolide acetate ... $4.95 - PR Newswire - ECNext Federal Register 2005 - 70 FR 58713 Solicitation of Public Review and... - Oct 7, 2005 The specific aim of the study is to test the hypothesis that the response to the injection of the GnRH agonist, leuprolide acetate, will distinguish among ... Pay-Per-View - Federal Register 2005 - Loislaw Article: Drug may prevent prostate Ca in high-risk patients: prostatic... - Oct 15, 2005 4 Month 30 mg (leuprolide acetate ... treatment of advanced prostate cancer. Because of the ... Depot-4 Month 30 mg every 16 weeks ... their condition. ... Pay-Per-View - Family Practice News - HighBeam Research Article: Toremifene may prevent prostate cancer in high-risk patients.... - Aug 15, 2005 4 Month 30 mg (leuprolide acetate ... treatment of advanced prostate cancer. Because of the ... Depot-4 Month 30 mg every 16 weeks ... their condition. ... Pay-Per-View - Internal Medicine News - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |